Related Experiment Video
Updated: Apr 18, 2026
12:52
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
16.7K
Dexmedetomidine in the supratentorial craniotomy
Osman Ilhan1, Senem Koruk2, Gokcen Serin3
1Elbistan State Hospital, Anesthesiology and Reanimation Clinic, Kahramanmaraş, Turkey.
The Eurasian Journal of Medicine
|January 23, 2015
Summary
Dexmedetomidine provided superior hemodynamic control and faster recovery compared to fentanyl in supratentorial craniotomies. This suggests dexmedetomidine is a safer and more effective agent for neuroanesthesia.
Area of Science:
- Anesthesiology
- Neurosurgery
- Pharmacology
Background:
- Supratentorial craniotomies require careful hemodynamic management.
- Fentanyl is a commonly used analgesic in neuroanesthesia.
- Dexmedetomidine offers potential benefits as an adjuvant anesthetic agent.
Purpose of the Study:
- To compare the effects of dexmedetomidine and fentanyl as adjuvant agents in supratentorial craniotomies.
- To evaluate hemodynamic changes, brain edema, recovery times, and side effects.
- To determine the safety and efficacy of dexmedetomidine versus fentanyl in neuroanesthesia.
Main Methods:
- Double-blind prospective clinical study.
- 30 ASA physical status I-II patients undergoing intracranial tumor surgery.
- Randomized groups: dexmedetomidine infusion vs. fentanyl infusion.
Main Results:
- Dexmedetomidine group showed significantly lower mean arterial pressure and heart rate.
- Shorter recovery times and reduced supplemental opioid requirement in the dexmedetomidine group.
- No shivering, nausea, or vomiting observed with dexmedetomidine postoperatively.
Conclusions:
- Dexmedetomidine offers superior perioperative hemodynamic control compared to fentanyl.
- Dexmedetomidine is associated with faster recovery and fewer side effects.
- Dexmedetomidine is a safer and more effective agent for neuroanesthesia during surgical stimulation.
Related Concept Videos
01:24Parenteral Anesthetics: Overview
972
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
972
01:19Depolarizing Blockers: Pharmocokinetics
745
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
745